Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18365556 | 1.00 | KDM4E (0.35) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL18561192 | 0.98 | KDM4E (0.35) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL18561176 | 0.97 | KDM4E (0.35) | KDM4EATML3MBTL1HDAC4F2 | |
| SCHEMBL18310205 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL16947133 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL18561234 | 0.95 | KDM4E (0.37) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL18561212 | 0.95 | KDM4E (0.37) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL16947129 | 0.94 | L3MBTL1 (0.41) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL17056424 | 0.94 | L3MBTL1 (0.41) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL18365628 | 0.93 | KDM4E (0.35) | KDM4EATML3MBTL1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200243771-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2020-07-30 | — | — | US | disclosed |
| US-10396291-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2019-08-27 | — | — | US | disclosed |
| US-20190051836-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2019-02-14 | — | — | US | disclosed |
| US-20160365517-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2016-12-15 | — | — | US | disclosed |
| US-20160365517-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2016-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10396291-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | GPX1, NFE2L2, LEF1 | KDM4E 1031/4885ATM 3863/4885L3MBTL1 284/4885 |
| US-20200243771-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | GPX1, LEF1, NFE2L2 | KDM4E 980/4885ATM 3822/4885L3MBTL1 258/4885 |
| US-20160365517-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | GPX1, NFE2L2, LEF1 | KDM4E 1031/4885ATM 3863/4885L3MBTL1 284/4885 |
| US-20190051836-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | GPX1, NFE2L2, LEF1 | KDM4E 1031/4885ATM 3863/4885L3MBTL1 284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.